Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor
Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized treatment. Patient-derived organoid culture is a strategy that may allow for the personalized study of esophageal adenocarcinoma and the dev...
Saved in:
Published in | Scientific reports Vol. 10; no. 1; p. 14514 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
03.09.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 2045-2322 2045-2322 |
DOI | 10.1038/s41598-020-71589-4 |
Cover
Abstract | Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized treatment. Patient-derived organoid culture is a strategy that may allow for the personalized study of esophageal adenocarcinoma and the development of personalized induction therapy. We therefore developed a protocol to establish EAC organoids from endoscopic biopsies of naïve esophageal adenocarcinomas. Histologic characterization and molecular characterization of organoids by whole exome sequencing demonstrated recapitulation of the tumors’ histology and genomic (~ 60% SNV overlap) characteristics. Drug testing using clinically appropriate chemotherapeutics and targeted therapeutics showed an overlap between the patient’s tumor response and the corresponding organoids’ response. Furthermore, we identified Barrett’s esophagus epithelium as a potential source of organoid culture contamination. In conclusion, organoids can be robustly cultured from endoscopic biopsies of esophageal adenocarcinoma and recapitulate the originating tumor. This model demonstrates promise as a tool to better personalize therapy for esophageal adenocarcinoma patients. |
---|---|
AbstractList | Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized treatment. Patient-derived organoid culture is a strategy that may allow for the personalized study of esophageal adenocarcinoma and the development of personalized induction therapy. We therefore developed a protocol to establish EAC organoids from endoscopic biopsies of naïve esophageal adenocarcinomas. Histologic characterization and molecular characterization of organoids by whole exome sequencing demonstrated recapitulation of the tumors' histology and genomic (~ 60% SNV overlap) characteristics. Drug testing using clinically appropriate chemotherapeutics and targeted therapeutics showed an overlap between the patient's tumor response and the corresponding organoids' response. Furthermore, we identified Barrett's esophagus epithelium as a potential source of organoid culture contamination. In conclusion, organoids can be robustly cultured from endoscopic biopsies of esophageal adenocarcinoma and recapitulate the originating tumor. This model demonstrates promise as a tool to better personalize therapy for esophageal adenocarcinoma patients.Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized treatment. Patient-derived organoid culture is a strategy that may allow for the personalized study of esophageal adenocarcinoma and the development of personalized induction therapy. We therefore developed a protocol to establish EAC organoids from endoscopic biopsies of naïve esophageal adenocarcinomas. Histologic characterization and molecular characterization of organoids by whole exome sequencing demonstrated recapitulation of the tumors' histology and genomic (~ 60% SNV overlap) characteristics. Drug testing using clinically appropriate chemotherapeutics and targeted therapeutics showed an overlap between the patient's tumor response and the corresponding organoids' response. Furthermore, we identified Barrett's esophagus epithelium as a potential source of organoid culture contamination. In conclusion, organoids can be robustly cultured from endoscopic biopsies of esophageal adenocarcinoma and recapitulate the originating tumor. This model demonstrates promise as a tool to better personalize therapy for esophageal adenocarcinoma patients. Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized treatment. Patient-derived organoid culture is a strategy that may allow for the personalized study of esophageal adenocarcinoma and the development of personalized induction therapy. We therefore developed a protocol to establish EAC organoids from endoscopic biopsies of naïve esophageal adenocarcinomas. Histologic characterization and molecular characterization of organoids by whole exome sequencing demonstrated recapitulation of the tumors’ histology and genomic (~ 60% SNV overlap) characteristics. Drug testing using clinically appropriate chemotherapeutics and targeted therapeutics showed an overlap between the patient’s tumor response and the corresponding organoids’ response. Furthermore, we identified Barrett’s esophagus epithelium as a potential source of organoid culture contamination. In conclusion, organoids can be robustly cultured from endoscopic biopsies of esophageal adenocarcinoma and recapitulate the originating tumor. This model demonstrates promise as a tool to better personalize therapy for esophageal adenocarcinoma patients. |
ArticleNumber | 14514 |
Author | Derouet, Mathieu F. Kalimuthu, Sangeetha Darling, Gail E. Allen, Jonathan Ng, Christine Tsao, Ming-Sound Yeung, Jonathan C. Radulovich, Nikolina Wilson, Gavin W. |
Author_xml | – sequence: 1 givenname: Mathieu F. surname: Derouet fullname: Derouet, Mathieu F. organization: Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network – sequence: 2 givenname: Jonathan surname: Allen fullname: Allen, Jonathan organization: Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network – sequence: 3 givenname: Gavin W. surname: Wilson fullname: Wilson, Gavin W. organization: Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network – sequence: 4 givenname: Christine surname: Ng fullname: Ng, Christine organization: Princess Margaret Cancer Centre, University Health Network – sequence: 5 givenname: Nikolina surname: Radulovich fullname: Radulovich, Nikolina organization: Princess Margaret Cancer Centre, University Health Network – sequence: 6 givenname: Sangeetha surname: Kalimuthu fullname: Kalimuthu, Sangeetha organization: Department of Pathology, University Health Network – sequence: 7 givenname: Ming-Sound surname: Tsao fullname: Tsao, Ming-Sound organization: Princess Margaret Cancer Centre, University Health Network, Department of Pathology, University Health Network – sequence: 8 givenname: Gail E. surname: Darling fullname: Darling, Gail E. organization: Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network, Division of Thoracic Surgery, Toronto General Hospital, University Health Network – sequence: 9 givenname: Jonathan C. surname: Yeung fullname: Yeung, Jonathan C. email: jonathan.yeung@uhn.ca organization: Latner Thoracic Surgery Research Laboratories, Princess Margaret Cancer Research Tower, University Health Network, Division of Thoracic Surgery, Toronto General Hospital, University Health Network |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32884042$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1TAQhSNUREvpC7BAltiwCfgvicMCCVX8SZXYlLXl2JN7XSWeYDtFl9fghfHltlC6qDe2NWc-Hc2cp9VRwABV9ZzR14wK9SZJ1vSqppzWHWtUX8tH1Qmnsqm54Pzozvu4OkvpipbT8F6y_kl1LLhSkkp-Uv26xB8mukQWiAmDmfxPcMQHt9rsMZC8hWiWHRkxEki4bM0GzESMg4DWROsDzuYtwbgxAX3hOIj-uiDGiDOB4DBZXLwlg8cl7UgEaxaf18lk2MPJEqHOEUyeIWSS1xnjs-rxaKYEZzf3afXt44fL88_1xddPX87fX9S2kTTX3CkFowAYzMhGTgUtH6HGAZgdeNsK1jlrVe-UcIMTzdgOrO-EKJV2bI0Vp9W7A3dZhxmcLQaimfQS_WziTqPx-v9K8Fu9wWvdyY51tCmAVzeAiN9XSFnPPlmYJhMA16S5LENuG8Flkb68J73CNZZ5FxVlvVSS0b3qxV1Hf63c7qsI1EFgI6YUYdTWZ7PfVDHoJ82o3qdDH9KhSzr0n3ToPZvfa72lP9gkDk2piMMG4j_bD3T9BnWS0cQ |
CitedBy_id | crossref_primary_10_1016_j_jcmgh_2024_01_017 crossref_primary_10_1016_j_gendis_2023_02_052 crossref_primary_10_1016_j_pharmthera_2022_108276 crossref_primary_10_3390_ijms242216098 crossref_primary_10_32604_oncologie_2022_024035 crossref_primary_10_3389_fmolb_2024_1440670 crossref_primary_10_1186_s12885_023_11434_9 crossref_primary_10_1038_s41598_021_85530_w crossref_primary_10_1016_j_canlet_2021_03_031 crossref_primary_10_3389_fonc_2021_641980 crossref_primary_10_1007_s00109_023_02340_5 crossref_primary_10_3389_fmolb_2024_1382070 crossref_primary_10_1186_s13059_021_02364_5 crossref_primary_10_3390_cancers13194812 crossref_primary_10_1016_j_biomaterials_2022_121417 crossref_primary_10_3390_cells13161312 crossref_primary_10_1136_gutjnl_2021_326560 crossref_primary_10_1007_s12015_024_10733_3 crossref_primary_10_1016_j_coph_2023_102348 crossref_primary_10_1038_s12276_021_00654_3 crossref_primary_10_1038_s41598_021_00706_8 crossref_primary_10_1038_s41467_023_38891_x crossref_primary_10_3390_cancers16213664 crossref_primary_10_3390_cancers14071806 crossref_primary_10_1016_j_jmb_2021_167256 crossref_primary_10_1186_s40164_023_00433_y crossref_primary_10_15283_ijsc24047 crossref_primary_10_1038_s41397_022_00296_2 crossref_primary_10_1016_j_labinv_2023_100105 crossref_primary_10_1016_j_medj_2021_08_005 crossref_primary_10_1360_SSV_2021_0315 crossref_primary_10_3390_cells9122649 crossref_primary_10_1038_s41417_023_00652_9 crossref_primary_10_1177_20417314241255470 crossref_primary_10_1002_term_3234 crossref_primary_10_1038_s12276_024_01272_5 |
Cites_doi | 10.1016/S1470-2045(14)70028-2 10.1016/j.ccell.2019.06.003 10.1007/978-3-030-11096-3_5 10.1101/gr.107524.110 10.1038/ng.3013 10.1186/s13059-016-0974-4 10.1038/s41588-018-0331-5 10.1056/NEJMoa1112088 10.1109/MCSE.2007.55 10.1053/gast.2003.50091 10.1038/s41467-018-05190-9 10.1038/ng.2591 10.1371/journal.pone.0146021 10.1093/bioinformatics/btp352 10.1038/s41592-018-0051-x 10.1042/BC20100071 10.1053/j.gastro.2011.07.050 10.18632/oncotarget.10667 10.1093/bioinformatics/btp324 10.1126/science.aao2774 10.1056/NEJMoa055531 10.1016/j.cell.2015.03.053 10.1053/j.gastro.2014.09.042 10.1158/2159-8290.CD-18-0349 10.1007/978-3-319-24277-4 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.1038/s41598-020-71589-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
ExternalDocumentID | PMC7471705 32884042 10_1038_s41598_020_71589_4 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c540t-2d88ef3eebaf1f2030f3e38fbe1cb266317dcc89d83dbd35f6b197336636f6ac3 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Thu Aug 21 18:12:30 EDT 2025 Fri Sep 05 00:20:04 EDT 2025 Wed Aug 13 04:34:17 EDT 2025 Thu Apr 03 07:05:55 EDT 2025 Thu Apr 24 23:44:06 EDT 2025 Tue Jul 01 02:46:18 EDT 2025 Fri Feb 21 02:39:00 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-2d88ef3eebaf1f2030f3e38fbe1cb266317dcc89d83dbd35f6b197336636f6ac3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/s41598-020-71589-4 |
PMID | 32884042 |
PQID | 2019484104 |
PQPubID | 2041939 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7471705 proquest_miscellaneous_2440465324 proquest_journals_2019484104 pubmed_primary_32884042 crossref_citationtrail_10_1038_s41598_020_71589_4 crossref_primary_10_1038_s41598_020_71589_4 springer_journals_10_1038_s41598_020_71589_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-09-03 |
PublicationDateYYYYMMDD | 2020-09-03 |
PublicationDate_xml | – month: 09 year: 2020 text: 2020-09-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Cunningham (CR2) 2006; 355 Tiriac (CR8) 2018; 8 Haigh (CR19) 2003; 124 CR30 Liu, Duong, Phillips, Clemons (CR7) 2016; 22 McKenna (CR25) 2010; 20 Li (CR23) 2009; 25 Li (CR10) 2018; 9 Underwood (CR6) 2010; 102 Dulak (CR16) 2013; 45 Vlachogiannis (CR18) 2018; 359 Xian (CR14) 2019; 1123 Conroy (CR3) 2014; 15 Kim (CR26) 2018; 15 McLaren (CR27) 2016; 17 Garcia (CR5) 2019; 9 CR4 Ritz, Baty, Streibig, Gerhard (CR31) 2015; 10 Baccelli (CR12) 2019; 36 Bartfeld (CR13) 2015; 148 Lee (CR20) 2017; 8 CR29 van Hagen (CR1) 2012; 366 Sato (CR15) 2011; 141 CR28 van de Wetering (CR9) 2015; 161 CR24 Li, Durbin (CR22) 2009; 25 Hunter (CR32) 2007; 9 CR21 Frankell (CR11) 2019; 51 Weaver (CR17) 2014; 46 S Bartfeld (71589_CR13) 2015; 148 71589_CR28 71589_CR29 P van Hagen (71589_CR1) 2012; 366 X Li (71589_CR10) 2018; 9 CR Haigh (71589_CR19) 2003; 124 71589_CR21 H Li (71589_CR23) 2009; 25 Y Lee (71589_CR20) 2017; 8 71589_CR24 JD Hunter (71589_CR32) 2007; 9 AM Frankell (71589_CR11) 2019; 51 T Sato (71589_CR15) 2011; 141 S Kim (71589_CR26) 2018; 15 71589_CR4 W Xian (71589_CR14) 2019; 1123 M van de Wetering (71589_CR9) 2015; 161 TJ Underwood (71589_CR6) 2010; 102 D Cunningham (71589_CR2) 2006; 355 W McLaren (71589_CR27) 2016; 17 DS Liu (71589_CR7) 2016; 22 C Ritz (71589_CR31) 2015; 10 H Li (71589_CR22) 2009; 25 I Baccelli (71589_CR12) 2019; 36 A McKenna (71589_CR25) 2010; 20 JMJ Weaver (71589_CR17) 2014; 46 G Vlachogiannis (71589_CR18) 2018; 359 71589_CR30 H Tiriac (71589_CR8) 2018; 8 T Conroy (71589_CR3) 2014; 15 E Garcia (71589_CR5) 2019; 9 AM Dulak (71589_CR16) 2013; 45 |
References_xml | – volume: 15 start-page: 305 year: 2014 end-page: 314 ident: CR3 article-title: Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): Final results of a randomised, phase 2/3 trial publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(14)70028-2 – volume: 36 start-page: 84 year: 2019 end-page: 99.e88 ident: CR12 article-title: Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.06.003 – volume: 1123 start-page: 55 year: 2019 end-page: 69 ident: CR14 article-title: The cellular origin of barrett's esophagus and its stem cells publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-11096-3_5 – volume: 20 start-page: 1297 year: 2010 end-page: 1303 ident: CR25 article-title: The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data publication-title: Genome Res doi: 10.1101/gr.107524.110 – ident: CR4 – volume: 9 start-page: 32417 year: 2019 ident: CR5 article-title: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 publication-title: Sci. Rep. – volume: 46 start-page: 837 year: 2014 end-page: 843 ident: CR17 article-title: Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis publication-title: Nat Genet doi: 10.1038/ng.3013 – ident: CR30 – volume: 22 start-page: 371 year: 2016 end-page: 379 ident: CR7 article-title: Preclinical models of esophageal adenocarcinoma for drug development publication-title: Discov .Med. – volume: 17 start-page: 122 year: 2016 ident: CR27 article-title: The ensembl variant effect predictor publication-title: Genome Biol doi: 10.1186/s13059-016-0974-4 – volume: 51 start-page: 506 year: 2019 end-page: 516 ident: CR11 article-title: The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic publication-title: Nat. Genet. doi: 10.1038/s41588-018-0331-5 – ident: CR29 – volume: 366 start-page: 2074 year: 2012 end-page: 2084 ident: CR1 article-title: Preoperative chemoradiotherapy for esophageal or junctional cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1112088 – volume: 9 start-page: 90 year: 2007 end-page: 95 ident: CR32 article-title: Matplotlib: a 2D graphics environment publication-title: Comput. Sci. & Eng. doi: 10.1109/MCSE.2007.55 – volume: 124 start-page: 615 year: 2003 end-page: 625 ident: CR19 article-title: Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor publication-title: Gastroenterology doi: 10.1053/gast.2003.50091 – ident: CR21 – volume: 9 start-page: 2983 year: 2018 ident: CR10 article-title: Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics publication-title: Nat. Commun. doi: 10.1038/s41467-018-05190-9 – volume: 45 start-page: 478 year: 2013 end-page: 486 ident: CR16 article-title: Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity publication-title: Nat Genet doi: 10.1038/ng.2591 – volume: 10 start-page: e0146021 year: 2015 ident: CR31 article-title: Dose-response analysis using R publication-title: PLoS ONE doi: 10.1371/journal.pone.0146021 – volume: 25 start-page: 2078 year: 2009 end-page: 2079 ident: CR23 article-title: The sequence alignment/map format and SAM tools publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp352 – volume: 15 start-page: 591 year: 2018 end-page: 594 ident: CR26 article-title: Strelka2: Fast and accurate calling of germline and somatic variants publication-title: Nat Methods doi: 10.1038/s41592-018-0051-x – volume: 102 start-page: 635 year: 2010 end-page: 644 ident: CR6 article-title: A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture publication-title: Biol. Cell doi: 10.1042/BC20100071 – volume: 141 start-page: 1762 year: 2011 end-page: 1772 ident: CR15 article-title: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.07.050 – volume: 8 start-page: 203 year: 2017 end-page: 214 ident: CR20 article-title: Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus publication-title: Oncotarget doi: 10.18632/oncotarget.10667 – volume: 25 start-page: 1754 year: 2009 end-page: 1760 ident: CR22 article-title: Fast and accurate short read alignment with Burrows-Wheeler transform publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – ident: CR28 – volume: 359 start-page: 920 year: 2018 end-page: 926 ident: CR18 article-title: Patient-derived organoids model treatment response of metastatic gastrointestinal cancers publication-title: Science doi: 10.1126/science.aao2774 – ident: CR24 – volume: 355 start-page: 11 year: 2006 end-page: 20 ident: CR2 article-title: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa055531 – volume: 161 start-page: 933 year: 2015 end-page: 945 ident: CR9 article-title: Prospective derivation of a living organoid biobank of colorectal cancer patients publication-title: Cell doi: 10.1016/j.cell.2015.03.053 – volume: 148 start-page: 126 year: 2015 end-page: 136.e126 ident: CR13 article-title: In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.09.042 – volume: 8 start-page: 1112 year: 2018 end-page: 1129 ident: CR8 article-title: Organoid profiling identifies common responders to chemotherapy in pancreatic cancer publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0349 – volume: 15 start-page: 591 year: 2018 ident: 71589_CR26 publication-title: Nat Methods doi: 10.1038/s41592-018-0051-x – volume: 46 start-page: 837 year: 2014 ident: 71589_CR17 publication-title: Nat Genet doi: 10.1038/ng.3013 – volume: 9 start-page: 32417 year: 2019 ident: 71589_CR5 publication-title: Sci. Rep. – volume: 355 start-page: 11 year: 2006 ident: 71589_CR2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa055531 – volume: 17 start-page: 122 year: 2016 ident: 71589_CR27 publication-title: Genome Biol doi: 10.1186/s13059-016-0974-4 – ident: 71589_CR29 doi: 10.1007/978-3-319-24277-4 – volume: 10 start-page: e0146021 year: 2015 ident: 71589_CR31 publication-title: PLoS ONE doi: 10.1371/journal.pone.0146021 – volume: 15 start-page: 305 year: 2014 ident: 71589_CR3 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(14)70028-2 – volume: 9 start-page: 90 year: 2007 ident: 71589_CR32 publication-title: Comput. Sci. & Eng. doi: 10.1109/MCSE.2007.55 – volume: 161 start-page: 933 year: 2015 ident: 71589_CR9 publication-title: Cell doi: 10.1016/j.cell.2015.03.053 – volume: 20 start-page: 1297 year: 2010 ident: 71589_CR25 publication-title: Genome Res doi: 10.1101/gr.107524.110 – volume: 8 start-page: 203 year: 2017 ident: 71589_CR20 publication-title: Oncotarget doi: 10.18632/oncotarget.10667 – ident: 71589_CR4 – volume: 51 start-page: 506 year: 2019 ident: 71589_CR11 publication-title: Nat. Genet. doi: 10.1038/s41588-018-0331-5 – volume: 36 start-page: 84 year: 2019 ident: 71589_CR12 publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.06.003 – volume: 141 start-page: 1762 year: 2011 ident: 71589_CR15 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.07.050 – volume: 359 start-page: 920 year: 2018 ident: 71589_CR18 publication-title: Science doi: 10.1126/science.aao2774 – volume: 8 start-page: 1112 year: 2018 ident: 71589_CR8 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0349 – volume: 9 start-page: 2983 year: 2018 ident: 71589_CR10 publication-title: Nat. Commun. doi: 10.1038/s41467-018-05190-9 – ident: 71589_CR21 – volume: 102 start-page: 635 year: 2010 ident: 71589_CR6 publication-title: Biol. Cell doi: 10.1042/BC20100071 – volume: 25 start-page: 2078 year: 2009 ident: 71589_CR23 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp352 – volume: 25 start-page: 1754 year: 2009 ident: 71589_CR22 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – volume: 22 start-page: 371 year: 2016 ident: 71589_CR7 publication-title: Discov .Med. – ident: 71589_CR30 – ident: 71589_CR28 – volume: 148 start-page: 126 year: 2015 ident: 71589_CR13 publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.09.042 – volume: 45 start-page: 478 year: 2013 ident: 71589_CR16 publication-title: Nat Genet doi: 10.1038/ng.2591 – ident: 71589_CR24 – volume: 366 start-page: 2074 year: 2012 ident: 71589_CR1 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1112088 – volume: 1123 start-page: 55 year: 2019 ident: 71589_CR14 publication-title: Adv Exp Med Biol doi: 10.1007/978-3-030-11096-3_5 – volume: 124 start-page: 615 year: 2003 ident: 71589_CR19 publication-title: Gastroenterology doi: 10.1053/gast.2003.50091 |
SSID | ssj0000529419 |
Score | 2.4773762 |
Snippet | Esophageal adenocarcinoma has few known recurrent mutations and therefore robust, reliable and reproducible patient-specific models are needed for personalized... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 14514 |
SubjectTerms | 631/67/1504/1477 631/67/70 Adenocarcinoma - drug therapy Adult Aged Aged, 80 and over Barrett Esophagus - drug therapy Chemotherapy Esophageal cancer Esophageal Neoplasms - drug therapy Female Filamentation Histology Humanities and Social Sciences Humans Induction Chemotherapy - methods Induction therapy Lasers Male Middle Aged multidisciplinary Organoids - cytology Precision Medicine - methods Science Science (multidisciplinary) Surgery Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB5qi-CLeG2jVVbwTYNJdpNsfJFSLEXQpxbOW8jeMGCT9CRHOP4N_7Azm0s5lvbxkM3mJDM7883O7HwA7wmw8Ui50DihQiEKiWsuSUOD7oVrbbn23IDff2Tnl-LbKl1NG279VFY520RvqE2raY8cg3QMt6XA6OFLdx0SaxRlVycKjQdwECMSIeqGfJUveyyUxRJxMZ2Vibj81KO_ojNlGDPlcSqLUOz6o1sg83at5H8JU--Hzp7A4wlAspNR4k9hzzbP4OFIKbl9Dn8vfB1sz7oZZf-xhmHgPXaJZeN5qy1DrMosURigPcHpKjQ_6NXWum7aq-oz82RPbY3zGFTR3zgFnUNhtjEtnWOpNVN12_Vbhgaz6uqBSMAsTc6orGSpXmfD5qpdv4DLs68Xp-fhRLwQagRwQ5gYKa3j1qrKxS5BO4A_uHTKxlqhR0fMYbSWhZHcKMNTl6m4oL6KGc9cVmn-EvabtrFHwDhGYDbPtXIGxYdozLgqyrREq-pMlKoA4vnzl3rqSk7kGL9Knx3nshxFVqLISi-yUgTwYbmnG3ty3Dv6eJZqOa3PvrzRpgDeLZdxZVG6pGpsu8Ex1DoxSxFxBnA4KsHyOJ5IjIxFEkC-ox7LAOravXulqX_67t20C5BHaQAfZ0W6-Vt3v8Wr-9_iNTxKSKkp08WPYX9Yb-wbREuDeuuXxD_B9xdk priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7ULYIvReul0Soj-KbBJDNJJr4tpaUs2Bdb6FvI3DBgk2U3W1j_hn_YcyYXWauFPoaZTCaZc_lOzg3gAwE2HikXGidUKEQhkeeSNDSoXrjWlmvfG_DrRXZ-JRbX6fUeJGMujA_a9yUtvZgeo8M-r1HRUDIYGjt5nMoiFI9gX-YofmewP58vvi2mPyvkuxJxMWTIRFz-4-ZdLXQHWt6NkPzLTeq1z9lTOBhgI5v3G30Ge7Y5hMd9I8ntc_h16aNf12w5Yuuf1jA0t_vasKzPstoyRKjMUuMClCK4XIVCB3XZStdNe1N9Yb7FU1vjOgYJ8xaXoOwTZhvTUvZKrZmq2-V6y1BMVsu6o9ZflhZnFEwyxayzbnPTrl7A1dnp5cl5OLRbCDXCti5MjJTWcWtV5WKXIPfjBZdO2Vgr1OOINIzWsjCSG2V46jIVF1RNMeOZyyrNX8KsaRt7BIyj3WXzXCtnCpQQvDCuijItUZY6E6UqgHj8_KUeapFTS4wfpfeJc1n2R1bikZX-yEoRwMfpnmVfiePe2cfjqZYDV65LBDu4HYEWaADvp2HkJ3KSVI1tNziHCiZmKeLMAF71RDA9jicS7WGRBJDvkMc0gWp174409Xdfs5ts_zxKA_g0EtKfbf3_LV4_bPobeJIQkZO_ix_DrFtt7FvETJ16NzDJb2XrFrk priority: 102 providerName: Springer Nature |
Title | Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor |
URI | https://link.springer.com/article/10.1038/s41598-020-71589-4 https://www.ncbi.nlm.nih.gov/pubmed/32884042 https://www.proquest.com/docview/2019484104 https://www.proquest.com/docview/2440465324 https://pubmed.ncbi.nlm.nih.gov/PMC7471705 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFD70wkZfxu511wUN9rZ5iy3ZlgtlZKGlBFbG1kDejHVjhtZOE6cs-xv7wzuSLyNruydjS5Zl6-ic7_jcAN5awEaHwvjKMOEzlnLcc2HkKxQvVEpNpasN-OU8PpuyySyabUFX7qj9gMs7VTtbT2q6uPzw83r9CTf8cRMyzj8uUQjZQDFUhJIg4qnPtmHX2YusK18L95tc32HKgrSNnbn71j14SEOOag8LN0XVLfx5243yH1uqE1Gnj-FRiy3JqCGGJ7Cly6fwoKk2uX4Gvy-ci-ySzDsA_ksrgjp5k0CWNKFYa4Iwlmhb3QBZDQ6XI2dCgbeQRVld5UfE1YGqChxHIfXe4BA2RIXoUlU2xKWQRBTVfLkmyEvzeVHb-mDaDk6sx0nv2E7q1VW1eA7T05OL8Znf1mTwJWK72g8V59pQrUVuAhMii8ATyo3QgRQo7BGOKCl5qjhVQtHIxCJIbcrFmMYmziV9ATtlVep9IBSVM50kUhiVIhuhqTL5MJYcGa5Rw0h4EHSfP5NtwnJbN-Myc4ZzyrNm9TJcvcytXsY8eNffM2_Sdfy392G3qllHeRkiIpwOQzXVgzd9M246a0nJS12tsI_NqhhHCEY9eNkQQf-4jno8SDbIo-9gE3pvtpTFD5fY2_4gSIaRB-87Qvo7rfvf4uDeKbyCvdCStrV_0UPYqRcr_RoxVC0GsJ3MkgHsjkaT7xM8fj45__oNr47j8cD9lxi4rfMH2awgYA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEB6VVAheEDeGAosET2Bhe9fOGqlCHK1S2kYIpVLfXO8lLFE75ACFv8H_4bcx46sKFX3rY-T1OPbMzrFzfADPyWHjgXK-cUL5QqQS91wU-wbNC9facl1jAx6Ok9GR-HQcH2_An64XhsoqO51YK2pTaTojxyAdw20pMHp4O_3uE2oUZVc7CI28hVYw2_WIsbaxY9-ufmIIN9_e-4j8fhFFuzuTDyO_RRnwNXorCz8yUlrHrVW5C12EQo8_uHTKhlqh-UIDa7SWqZHcKMNjl6gwpSGCCU9ckmuOdK_ApqADlAFsvt8Zf_7Sn_JQHk2EadutE3D5eo4Wk7raMGobhrFMfbFuEc-5ueerNf9J2daWcPcm3GhdWPaukblbsGHL23C1AbVc3YHfk7oSd86mnZ__yxqGoX8zp5Y1HV8rht4yswSigBoNyeWoANGuznRRVqf5G1bDTVUF0jG4SX4gCeqEYbY0FXXSFJqpoprOVwxVdj4tFgRDZok4o8KWvn6eLZan1ewuHF0KU-7BoKxK-wAYxxjQDodaOYMChP6gcXmQaIl63ZkgVh6E3efPdDsXneA5vmV1fp7LrGFZhizLapZlwoOX_T3TZirIhau3Oq5mrYaYZ2fy7MGz_jLubUrY5KWtlriGhjcmMfq8HtxvhKB_HI8kxuYi8mC4Jh79Apobvn6lLL7W88PpHGIYxB686gTp7G_9_y0eXvwWT-HaaHJ4kB3sjfcfwfWIBJzybnwLBovZ0j5G322hnrQbhMHJZe_Jv7lqXDI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7UFsUX8W606gj6pKFJJpeJUERtl9bqUqSFvsXMDQM2ibtZZf0b_it_lefkVtZi3_q4ZDLZ5NznXD6A5-SwcU9aV9tQumGYCpS5IHI1mheulOGqxQb8NI33jsMPJ9HJGvwZemGorHLQia2i1pWiM3IM0jHcFiFGD1u2L4s43Jm8qb-7hCBFmdYBTiPvYRb0djturG_yODDLnxjOzbf3d5D2L4Jgsnv0fs_tEQdchZ5L4wZaCGO5MTK3vg1QAPAHF1YaX0k0ZWhstVIi1YJrqXlkY-mnNFAw5rGNc8Vx3yuwkaDVx0Bw493u9PDzeOJDObXQT_vOHY-LrTlaT-pwwwgu8SORuuGqdTzn8p6v3PwnfdtaxclNuNG7s-xtx3-3YM2Ut-FqB3C5vAO_j9qq3DmrB5__l9GsKHU3s5Z13V9Lhp4zMwSogNoNt8tRGaKNnamirE7z16yFnqoK3EejwPzALagrhplSV9RVUygmi6qeLxmq77wuGoIkM7Q5oyKXsZaeNYvTanYXji-FKPdgvaxK8wAYx3jQJImSViMzoW-obe7FSqCOt9qLpAP-8Pkz1c9IJ6iOb1mbq-ci60iWIcmylmRZ6MDL8Z66mxBy4erNgapZry3m2RlvO_BsvIxyTsmbvDTVAtfQIMc4Qv_XgfsdE4yP44HAOD0MHEhW2GNcQDPEV6-Uxdd2ljidSSRe5MCrgZHO_tb_3-LhxW_xFK6hbGYf96cHj-B6QPxNKTi-CevNbGEeoxvXyCe9fDD4ctki-RfeVmB2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Towards+personalized+induction+therapy+for+esophageal+adenocarcinoma%3A+organoids+derived+from+endoscopic+biopsy+recapitulate+the+pre-treatment+tumor&rft.jtitle=Scientific+reports&rft.au=Derouet%2C+Mathieu+F&rft.au=Allen%2C+Jonathan&rft.au=Wilson%2C+Gavin+W&rft.au=Ng%2C+Christine&rft.date=2020-09-03&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft.spage=14514&rft_id=info:doi/10.1038%2Fs41598-020-71589-4&rft_id=info%3Apmid%2F32884042&rft.externalDocID=32884042 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |